 |
|
|
REFERENCES
1.
Michenfelder JD: Anesthesia and the Brain: Clinical,
Functional, Metabolic, and Vascular Correlates. New York, Churchill Livingstone,
1988.
2.
Moncada S, Palmer RMJ, Higgs EA: Nitric oxide:
Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109–142,
1991.
3.
Snyder SH, Bredt DS: Biological roles of nitric
oxide. Sci Am 266:68–71, 74–77, 1992.
4.
Wang Q, Pelligrino DA, Baughman VL, et al: The
role of neuronal nitric oxide synthase in regulation of cerebral blood flow in normocapnia
and hypercapnia in rats. J Cereb Blood Flow Metab 15:774–778, 1995.
5.
McPherson RW, Kirsch JR, Ghaly RF, Traystman RJ:
Effect of nitric oxide synthase inhibition on the cerebral vascular response to
hypercapnia in primates. Stroke 26:682–687, 1995.
6.
Ayata C, Ma J, Meng W, et al: L-NA-sensitive rCBF
augmentation during vibrissal stimulation in type III nitric oxide synthase mutant
mice. J Cereb Blood Flow Metab 16:539–541, 1996.
7.
Cholet N, Seylaz J, Lacombe P, Bonvento G: Local
uncoupling of the cerebrovascular and metabolic responses to somatosensory stimulation
after neuronal nitric oxide synthase inhibition. J Cereb Blood Flow Metab 17:1191–1201,
1997.
8.
McPherson RW, Kirsch JR, Traystman RJ: Effect of
N-nitro-L-arginine
on cerebral vasodilation by halothane and isoflurane [abstract]. Anesthesiology
77:A173, 1992.
9.
Koenig HM, Pelligrino DA, Albrecht RF: Halothane
vasodilatation and nitric oxide in rat pial vessels [abstract]. Anesthesiology 77:A751,
1992.
10.
Koenig HM, Pelligrino DA, Wang Q, Albrecht RF:
Role of nitric oxide and endothelium in rat pial vessel dilation response to isoflurane.
Anesth Analg 79:886–891, 1994.
11.
Iadecola C: Nitric oxide participates in the cerebrovasodilation
elicited from cerebellar fastigial nucleus. Am J Physiol 263:R1156-R1161, 1992.
12.
Raszkiewicz JL, Linville DG, Kerwin JF, et al:
Nitric oxide synthase is critical in mediating basal forebrain regulation of cortical
cerebral circulation. J Neurosci Res 33:129–135, 1992.
13.
Kimura T, Yu J-G, Edvinsson L, Lee TJ-F: Cholinergic,
nitric oxidergic innervation in cerebral arteries of the cat. Brain Res 773:117–124,
1997.
14.
Lou HC, Edvinsson L, MacKenzie ET: The concept
of coupling blood flow to brain function: Revision required? Ann Neurol 22:289–297,
1987.
15.
Miyauchi Y, Sakabe T, Maekawa Y, et al: Responses
of EEG, cerebral oxygen consumption and blood flow to peripheral nerve stimulation
during thiopentone anaesthesia in the dog. Can Anaesth Soc J 32:491–498, 1985.
16.
Cameron OG, Modell JG, Hichwa RD, et al: Changes
in sensory-cognitive input: Effects on cerebral blood flow. J Cereb Blood Flow
Metab 10:38–42, 1990.
17.
Frostig RD, Lieke EE, Ts'o DY, Grinvald A: Cortical
functional architecture and local coupling between neuronal activity and the microcirculation
revealed by in vivo high-resolution optical imaging of intrinsic signals. Proc Natl
Acad Sci U S A 87:6082–6086, 1990.
18.
Perlmutter JS, Lich LL, Margenau W, Bucholz S:
PET measured evoked cerebral blood flow responses in an awake monkey. J Cereb Blood
Flow Metab 11:229–235, 1991.
19.
Hyder F, Behar KL, Martin MA, et al: Dynamic magnetic
resonance imaging of the rat brain during forepaw stimulation. J Cereb Blood Flow
Metab 14:649–655, 1994.
20.
Bonvento G, Lacombe P, Seylaz J: Effects of electrical
stimulation of the dorsal raphe nucleus on local cerebral blood flow in the rat.
J Cereb Blood Flow Metab 9:251–255, 1989.
21.
Michenfelder J: The interdependency of cerebral
function and metabolic effects following massive doses of thiopental in the dog.
Anesthesiology 41:231–236, 1974.
22.
Newberg LA, Milde JH, Michenfelder JD: The cerebral
metabolic effects of isoflurane at and above concentrations that suppress cortical
electrical activity. Anesthesiology 59:23–28, 1983.
23.
Scheller MS, Tateishi A, Drummond JC, Zornow MH:
The effects of sevoflurane on cerebral blood flow, cerebral metabolic rate for oxygen,
intracranial pressure, and the electroencephalogram are similar to those of isoflurane
in the rabbit. Anesthesiology 68:548–551, 1988.
24.
Rampil IJ, Laster M, Dwyer RC, et al: No EEG evidence
of acute tolerance to desflurane in swine. Anesthesiology 74:889–892, 1991.
25.
Bruhn J, Bouillon T, Shafer S: Onset of propofol-induced
burst suppression may be correctly detected as deepening of anaesthesia by approximate
entropy but not by bispectral index. Br J Anaesth 87:505–507, 2002.
26.
Milde LN, Milde JH, Michenfelder JD: Cerebral
functional, metabolic and hemodynamic effects of etomidate in dogs. Anesthesiology
63:371–377, 1985.
27.
Maekawa T, Tommasino C, Shapiro HM, et al: Local
cerebral blood flow and glucose utilization during isoflurane anesthesia in the rat.
Anesthesiology 65:144–151, 1986.
28.
Hansen TD, Warner DS, Todd MM, et al: Distribution
of cerebral blood flow during halothane versus isoflurane anesthesia in rats. Anesthesiology
69:332–337, 1988.
29.
Reinstrup P, Ryding E, Algotsson L, et al: Distribution
of cerebral blood flow during anesthesia with isoflurane or halothane in humans.
Anesthesiology 82:359–366, 1995.
30.
Drummond JC, Todd MM, U HS: The effect of high
dose sodium thiopental on brain stem auditory and median nerve somatosensory evoked
potentials in humans. Anesthesiology 63:249–254, 1985.
31.
Peterson DO, Drummond JC, Todd MM: The effects
of halothane, enflurane, isoflurane, and nitrous oxide on somatosensory evoked potentials
in humans. Anesthesiology 65:35–40, 1986.
32.
Akrawi WP, Drummond JC, Kalkman CJ, Patel PM:
A comparison of the electrophysiologic characteristics of EEG burst-suppression as
produced by isoflurane, thiopental, etomidate and propofol. J Neurosurg Anesthesiol
8:40–46, 1996.
33.
Maher J, Hachinski V: Hypothermia as a potential
treatment for cerebral ischemia. Cerebrovasc Brain Metab Rev 5:277–300, 1993.
34.
Kataoka K, Mitani A, Yanese H, et al: Ischemic
neuronal damage: How does mild hypothermia modulate it? Mol Clin Neuropathol 28:191–195,
1996.
35.
Nemoto EM, Klementavicius R, Melick JA, Yonas H:
Suppression of cerebral metabolic rate for oxygen (CMRO2
) by mild hypothermia
compared with thiopental. J Neurosurg Anesthesiol 8:52–59, 1996.
36.
Klementavicius R, Nemoto EM, Yonas H: The Q10
ratio basal cerebral metabolic rate for oxygen in rats. J Neurosurg 85:482–487,
1996.
37.
Busija DW, Leffler CW, Pourcyrous M: Hyperthermia
increases cerebral metabolic rate and blood flow in neonatal pigs. Am J Physiol
255:H343–H346, 1988.
38.
Smith AL, Wollman H: Cerebral blood flow and metabolism:
Effects of anesthetic drugs and techniques. Anesthesiology 36:378–400, 1972.
39.
Sato M, Pawlik G, Heiss WD: Comparative studies
of regional CNS blood flow autoregulation and responses to CO2
in the
cat. Stroke 15:91–97, 1984.
40.
Koehler RC, Traystman RJ: Bicarbonate ion modulation
of cerebral blood flow during hypoxia and hypercapnia. Am J Physiol 243:H33–H40,
1982.
41.
Iadecola C, Zhang F: Nitric oxide-dependent and
-independent components of cerebrovasodilation elicited by hypercapnia. Am J Physiol
266:R546–R552, 1994.
42.
Iadecola C, Xu X: Nitro-L-arginine
attenuates hypercapnic cerebrovasodilation without affecting cerebral metabolism.
Am J Physiol 266:R518–R525, 1994.
43.
Smith JJ, Lee JG, Hudetz AG, et al: The role of
nitric oxide in the cerebrovascular response to hypercapnia. Anesth Analg 84:363–369,
1997.
44.
Schmetterer L, Findl O, Strenn K, et al: Role
of NO in the O2
and CO2
responsiveness of cerebral and ocular
circulation in humans. Am J Physiol 273:R2005–R2012, 1997.
45.
Heinert G, Nye P, Paterson D: Nitric oxide and
prostaglandin pathways interact in the regulation of hypercapnic cerebral vasodilation.
Acta Physiol Scand 166:183–193, 1999.
46.
Albrecht RF, Miletich DJ, Madala LR: Normalization
of cerebral blood flow during prolonged halothane anesthesia. Anesthesiology 58:26–31,
1983.
47.
Raichle ME, Posner JB, Plum F: Cerebral blood
flow during and after hyperventilation. Arch Neurol 23:394–403, 1970.
48.
Plum F, Siesjo BK: Recent advances in CSF physiology.
Anesthesiology 42:708–730, 1975.
49.
Hudetz AG, Shen H, Kampine JP: Nitric oxide from
neuronal NOS plays a critical role in cerebral capillary flow response to hypoxia.
Am J Physiol 274:H982–H989, 1998.
50.
Golanov E, Reis DJ: Oxygen sensitive neurons of
the rostral ventrolateral medulla contribute to hypoxic cerebral vasodilation. J
Physiol (Lond) 495:201–216, 1996.
51.
Omae T, Ibayashi S, Kusuda K, et al: Effects of
high atmospheric pressure and oxygen on middle cerebral blood flow velocity in humans
measured by transcranial Doppler. Stroke 29:94–97, 1998.
52.
Jacobson I, Harper AM, McDowall DG: The effects
of oxygen at 1 and 2 atmospheres on the blood flow and oxygen uptake of the cerebral
cortex. Surg Gynecol Obstet 119:737–742, 1964.
53.
Drummond JC: The lower limit of autoregulation:
Time to revise our thinking [letter]? Anesthesiology 86:1431–1433, 1997.
54.
Strandgaard S: Autoregulation of cerebral blood
flow in hypertensive patients. The modifying influence of prolonged antihypertensive
treatment on the tolerance to acute, drug-induced hypotension. Circulation 53:720–727,
1976.
55.
Waldemar G, Schmidt JF, Andersen AR, et al: Angiotensin
converting enzyme inhibition and cerebral blood flow autoregulation in normotensive
and hypertensive man. J Hypertens 7:229–235, 1989.
56.
Larsen FS, Olsen KS, Hansen BA, et al: Transcranial
Doppler is valid for determination of the lower limit of cerebral blood flow autoregulation.
Stroke 25:1985–1988, 1994.
57.
Olsen KS, Svenden LB, Larsen FS, Paulson OB: Effect
of labetalol on cerebral blood flow, oxygen metabolism and autoregulation in healthy
humans. Br J Anaesth 75:51–54, 1995.
58.
Olsen KS, Svendsen LB, Larsen FS: Validation of
transcranial near-infrared spectroscopy for evaluation of cerebral blood flow autoregulation.
J Neurosurg Anesthesiol 8:280–285, 1996.
59.
Greenfield JC, Rembert JC, Tindall GT: Transient
changes in cerebral vascular resistance during the Valsalva maneuver in man. Stroke
15:76–79, 1984.
60.
Toyoda K, Fujii K, Ibayashi S, et al: Role of
nitric oxide in regulation of brain stem circulation during hypotension. J Cereb
Blood Flow Metab 17:1089–1096, 1997.
61.
Kobari M, Fukuuchi Y, Tomita M, et al: Role of
nitric oxide in regulation of cerebral microvascular tone and autoregulation of cerebral
blood flow in cats. Brain Res 667:255–262, 1994.
62.
Thompson BG, Pluta RM, Girton ME, Oldfield EH:
Nitric oxide mediation of chemoregulation but not autoregulation of cerebral blood
flow in primates. J Neurosurg 84:71–78, 1996.
63.
Branston NM: Neurogenic control of the cerebral
circulation. Cerebrovasc Brain Metab Rev 7:338–349, 1995.
64.
Dahl E: The innervation of the cerebral arteries.
J Anat 115:53–63, 1973.
65.
Hara H, Zhang Q-J, Kuroyanagi T, Kobayashi S:
Parasympathetic cerebrovascular innervation: An anterograde tracing from the sphenopalatine
ganglion in the rat. Neurosurgery 32:822–827, 1993.
66.
Sato A, Sato Y: Cerebral cortical vasodilatation
in response to stimulation of cholinergic fibres originating in the nucleus basalis
of Meynert. J Auton Nerv Syst 30(Suppl):S137–S140, 1990.
67.
Adachi T, Biesold D, Inanami O, Sato A: Stimulation
of the nucleus basalis of Meynert and substantia innominata produces widespread increases
in cerebral blood flow in the frontal, parietal and occipital cortices. Brain Res
514:163–166, 1990.
68.
Iadecola C, Reis DJ: Continuous monitoring of
cerebrocortical blood flow during stimulation of the cerebellar fastigial nucleus:
A study by laser-Doppler flowmetry. J Cereb Blood Flow Metab 10:608–617,
1990.
69.
Tuor UI: Local distribution of the effects of
sympathetic stimulation on cerebral blood flow in the rat. Brain Res 529:224–231,
1990.
70.
Reddy SVR, Yaksh TL, Anderson RE Jr, Sundt TM Jr:
Effect in cat of locus coeruleus lesions on the response of cerebral blood flow
and cardiac output to altered PaCO2
.
Brain Res 365:278–288, 1985.
71.
Edvinsson L, Dequeurce A, Duverger D, et al: Central
serotonergic nerves project to the pial vessels of the brain. Nature 306:55–57,
1983.
72.
Underwood MD, Bakalian MJ, Arango V, et al: Regulation
of cortical blood flow by the dorsal raphe nucleus: Topographic organization of
cerebrovascular regulatory regions. J Cereb Blood Flow Metab 12:664–673, 1992.
73.
Hara H, Jansen I, Ekman R, et al: Acetylcholine
and vasoactive intestinal peptide in cerebral blood vessels: Effect of extirpation
of the sphenopalatine ganglion. J Cereb Blood Flow Metab 9:204–211, 1989.
74.
Busija DW: Sympathetic nerves reduce cerebral
blood flow during hypoxia in awake rabbits. Am J Physiol 247:H446–H451, 1984.
75.
Auer LM, Edvinsson L, Johansson BB: Effect of
sympathetic nerve stimulation and adrenoceptor blockade on pial arterial and venous
calibre and on intracranial pressure in the cat. Acta Physiol Scand 119:213–217,
1983.
76.
MacKenzie ET, McGeorge AD, Graham DI, et al: Effects
of increasing arterial pressure on cerebral blood flow in the baboon, influence of
the sympathetic nervous system. Pflugers Arch 378:189–195, 1979.
77.
Bevan JA: Autonomic pharmacologist's guide to
the cerebral circulation. Trends Pharmacol Sci 5:234–236, 1984.
78.
Fitch W, MacKenzie ET, Harper AM: Effects of decreasing
arterial blood pressure on cerebral blood flow in the baboon. Influence of the sympathetic
nervous system. Circ Res 37:550–557, 1975.
79.
Johansson BB, Auer LM: Neurogenic modification
of the vulnerability of the blood-brain-barrier during acute hypertension in conscious
rats. Acta Physiol Scand 117:507–511, 1983.
80.
Tuor UI: Acute hypertension and sympathetic stimulation:
Local heterogeneous changes in cerebral blood flow. Am J Physiol 263:H511–H518,
1992.
81.
Reis DJ, Berger SB, Underwood MD, Khayata M: Electrical
stimulation of cerebellar fastigial nucleus reduces ischemic infarction elicited
by middle cerebral artery occlusion in rat. J Cereb Blood Flow Metab 11:810–818,
1991.
82.
Koketsu N, Moskowitz MA, Kontos HA, et al: Chronic
parasympathetic sectioning decreases regional cerebral blood flow during hemorrhagic
hypotension and increases infarct size after middle cerebral artery occlusion in
spontaneously hypertensive rats. J Cereb Blood Flow Metab 12:613–620, 1992.
83.
Shibata M, Einhaus S, Schweitzer JB, et al: Cerebral
blood flow decreased by adrenergic stimulation of cerebral vessels in anesthetized
newborn pigs with traumatic brain injury. J Neurosurg 79:696–704, 1993.
84.
MacFarlane R, Moskowitz MA, Sakas DE, et al: The
role of neuroeffector mechanisms in cerebral hyperperfusion syndromes. J Neurosurg
75:845–855, 1991.
85.
Harrison MG: Influence of haematocrit in the cerebral
circulation. Cerebrovasc Brain Metab Rev 1:55–67, 1989.
86.
Thomas DJ, Marshall J, Russell RW, et al: Effect
of haematocrit on cerebral blood-flow in man. Lancet 2:941–943, 1977.
87.
Cole DJ, Drummond JC, Patel PM, Marcantonio S:
Effects of viscosity and oxygen content on cerebral blood flow in ischemic and normal
rat brain. J Neurol Sci 124:15–20, 1994.
88.
Cole DJ, Drummond JC, Shapiro HM, et al: The effect
of hypervolemic-hemodilution with and without hypertension on cerebral blood flow
following middle cerebral artery occlusion in the rat. Anesthesiology 71:580–585,
1989.
89.
Korosue K, Ishida K, Matsuoka H, et al: Clinical,
hemodynamic, and hemorrheological effects of isovolemic hemodilution in acute cerebral
infarction. Neurosurgery 23:148–153, 1988.
90.
Origitano TC, Wascher TM, Reichman H, Anderson
DE: Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic
hemodilution ("triple-H" therapy) after subarachnoid hemorrhage. Neurosurg 27:729–740,
1990.
91.
Korosue K, Heros RC: Mechanism of cerebral blood
flow augmentation by hemodilution in rabbits. Stroke 23:1487–1493, 1992.
92.
Kee DB, Wood JH: Rheology of the cerebral circulation.
Neurosurgery 15:125–131, 1984.
93.
Lee SH, Heros RC, Mullan JC, Korosue K: Optimum
degree of hemodilution for brain protection in a canine model of focal cerebral ischemia.
J Neurosurg 80:469–475, 1994.
94.
Aichner FT, Fazekas F, Brainin M, et al: Hypervolemic
hemodilution in acute ischemic stroke: The Multicenter Austrian Hemodilution Stroke
Trial (MAHST). Stroke 29:743–749, 1998.
95.
Maekawa T, McDowall DG, Okuda Y: Brain-surface
oxygen tension and cerebral cortical blood flow during hemorrhagic and drug-induced
hypotension in the cat. Anesthesiology 51:313–320, 1979.
96.
Akopov S, Simonian N: Comparison of isradipine
and enalapril effects on regional carotid circulation in patients with hypertension
with unilateral carotid artery stenosis. J Cardiovasc Pharmacol 30:562–570,
1997.
97.
Marsh ML, Shapiro HM, Smith RW, Marshall LF: Changes
in neurologic status and intracranial pressure associated with sodium nitroprusside
administration. Anesthesiology 51:336–338, 1979.
98.
Olesen J: The effect of intracarotid epinephrine,
norepinephrine, and angiotensin on the regional cerebral blood flow in man. Neurology
22:978–987, 1972.
99.
MacKenzie ET, McCulloch J, O'Keane M, et al: Cerebral
circulation and norepinephrine: Relevance of the blood-brain barrier. Am J Physiol
231:483–488, 1976.
100.
Rogers AT, Stump DA, Gravlee GP, et al: Response
of cerebral blood flow to phenylephrine infusion during hypothermic cardiopulmonary
bypass: Influence of PaCO2
management.
Anesthesiology 69:547–551, 1988.
101.
Drummond JC, Oh Y-S, Cole DJ, Shapiro HM: Phenylephrine-induced
hypertension decreases the area of ischemia following middle cerebral artery occlusion
in the rat. Stroke 20:1538–1544, 1989.
102.
Berntman L, Dahlgren N, Siesjo BK: Influence
of intravenously administered catecholamines on cerebral oxygen consumption and blood
flow in the rat. Acta Physiol Scand 104:101–108, 1978.
103.
Tuor UI, Edvinsson L, McCulloch J: Catecholamines
and the relationship between cerebral blood flow and glucose use. Am J Physiol 251:H824–H833,
1986.
104.
Sokrab TE, Johansson BB: Regional cerebral blood
flow in acute hypertension induced by adrenaline, noradrenaline and phenylephrine
in the conscious rat. Acta Physiol Scand 137:101–106, 1989.
105.
Ekstrom-Jodal B, von Essen C, Haggendal E: Effects
of noradrenaline on the cerebral blood flow in the dog. Acta Neurol Scand 50:11–26,
1974.
106.
von Essen C: Effects of dopamine, noradrenaline
and 5-hydroxytryptamine on the cerebral blood flow in the dog. J Pharm Pharmacol
24:668, 1972.
107.
Oberdorster G, Lang R, Zimmer R: Direct effects
of alpha- and beta-sympathomimetic amines on the cerebral circulation of the dog.
Pflugers Arch 340:145–160, 1973.
108.
Lluch S, Reimann C, Glick G: Evidence for the
direct effect of adrenergic drugs on the cerebral vascular bed of the unanesthetized
goat. Stroke 4:50–56, 1973.
109.
Nemoto EM, Klementavicius R, Melick JA, Yonas
H: Norepinephrine activation of basal cerebral metabolic rate for oxygen (CMRO2
)
during hypothermia in rats. Anesth Analg 83:1262–1267, 1996.
110.
Artru A, Nugent M, Michenfelder JD: Anesthetics
affect the cerebral metabolic response to circulatory catecholamines. J Neurochem
36:1941–1946, 1981.
111.
Bryan RM: Cerebral blood flow and energy metabolism
during stress. Am J Physiol 259:H269–H280, 1990.
112.
Sercombe R, Aubineau P, Edvinsson L, et al: Pharmacological
evidence in vitro and in vivo for functional beta1
receptors in the cerebral
circulation. Pflugers Arch 368:241–244, 1977.
113.
King BD, Sokoloff L, Wechsler RL: The effects
of l-epinephrine and l-norepinephrine
upon cerebral circulation and metabolism in man. J Clin Invest 31:273–279,
1951.
114.
Abdul-Rahman A, Dahlgren N, Johansson BB, Siesjö
BK: Increase in local cerebral blood flow induced by circulating adrenaline: Involvement
of blood-brain barrier dysfunction. Acta Physiol Scand 107:227–232, 1979.
115.
Madsen PL, Vorstrup S, Schmidt JF, Paulson OB:
Effect of acute and prolonged treatment with propranolol on cerebral blood flow
and cerebral oxygen metabolism in healthy volunteers. Eur J Clin Pharmacol 39:295–297,
1990.
116.
Schroeder T, Schierbeck J, Howardy P, et al:
Effect of labetalol on cerebral blood flow and middle cerebral arterial flow velocity
in healthy volunteers. Neurol Res 13:10–12, 1991.
117.
Dubois M, Caputy A, MacCosbe P, et al: Cerebral
blood flow measurements during blood pressure control with intravenous labetalol
following craniotomy. J Neurosurg Anesthesiol 4:176–181, 1992.
118.
Howie MB, Black HA, Zvara D, et al: Esmolol reduces
autonomic hypersensitivity and length of seizures induced by electroconvulsive therapy.
Anesth Analg 71:384–388, 1990.
119.
Bunegin L, Albin MS, Gelineau EF: Effect of esmolol
on cerebral blood flow during intracranial hypertension and hemorrhagic hypovolemia
[abstract]. Anesthesiology 67:A424, 1987.
120.
von Essen C, Zervas NT, Brown DR, et al: Local
cerebral blood flow in the dog during intravenous infusion of dopamine. Surg Neurol
13:181–188, 1980.
121.
von Essen C: Effects of dopamine on the cerebral
blood flow in the dog. Acta Neurol Scand 50:39–52, 1974.
122.
Toda N: Dopamine vasodilates human cerebral artery.
Experientia 39:1131–1132, 1983.
123.
Bandres J, Yao L, Nemoto EM, et al: Effects of
dobutamine and dopamine on whole brain blood flow and metabolism in unanesthetized
monkeys. J Neurosurg Anesthesiol 4:250–256, 1992.
124.
Townsend JB, Ziedonis DM, Bryan RM, et al: Choroid
plexus blood flow: Evidence for dopaminergic influence. Brain Res 290:165–169,
1984.
125.
Karlsson B, Forsman M, Roald OK, et al: Effect
of dexmedetomidine, a selective and potent alpha2-agonist, on cerebral blood flow
and oxygen consumption during halothane anesthesia in dogs. Anesth Analg 71:125–129,
1990.
126.
James IM, Larbi E, Zaimis E: The effect of acute
intravenous administration of clonidine on cerebral blood flow in man. Br J Pharmacol
39:198P–199P, 1970.
127.
Kanawati IS, Yaksh TL, Anderson RE, Marsh RW:
Effects of clonidine on cerebral blood flow and the response to arterial CO2
.
J Cereb Blood Flow Metab 6:358–365, 1985.
128.
Crosby G, Russo MA, Szabo MD, Davies KR: Subarachnoid
clonidine reduces spinal cord blood flow and glucose utilization in conscious rats.
Anesthesiology 73:1179–1185, 1990.
129.
Lee H-W, Caldwell JE, Dodson B, et al: The effect
of clonidine on cerebral blood flow velocity, carbon dioxide cerebral vasoreactivity,
and response to increased arterial pressure in human volunteers. Anesthesiology
87:553–558, 1997.
130.
Coughlan MG, Lee JG, Bosnjak ZJ, et al: Direct
coronary and cerebral vascular responses to dexmedetomidine: Significance of endogenous
nitric oxide synthesis. Anesthesiology 77:998–1006, 1992.
131.
Busija DW, Leffler CW: Exogenous norepinephrine
constricts cerebral arterioles via α2
-adrenoceptors in newborn pigs.
J Cereb Blood Flow Metab 7:184–188, 1987.
132.
Zornow MH, Maze M, Dyck JB, Shafer SL: Dexmedetomidine
decreases cerebral blood flow velocity in humans. J Cereb Blood Flow Metab 13:350–353,
1993.
133.
Prielipp RC, Wall MH, Tobin JR, et al: Dexmedetomidine-induced
sedation in volunteers decreases regional and global cerebral blood flow. Anesth
Analg 95:1052–1059, 2002.
134.
Marchal G, Rioux P, Petit-Taboué M-C, et
al: Regional cerebral oxygen consumption, blood flow, and blood volume in healthy
human aging. Arch Neurol 49:1013–1020, 1992.
135.
Meyer JS, Terayama Y, Takashima S: Cerebral circulation
in the elderly. Cerebrovasc Brain Metabol Rev 5:122–146, 1993.
136.
Todd MM, Weeks J: Comparative effects of propofol,
pentobarbital, and isoflurane on cerebral blood flow and blood volume. J Neurosurg
Anesthesiol 8:296–303, 1996.
137.
Powers WJ, Raichle ME: Positron emission tomography
and its application to the study of cerebrovascular disease in man. Stroke 16:361–365,
1985.
138.
Greenberg JH, Alavi A, Reivich M, et al: Local
cerebral blood volume response to carbon dioxide in man. Circ Res 43:324–331,
1978.
139.
Grubb RL, Raichle ME, Eichling JO, Ter-Pogossian
MM: The effects of changes in PaCO2
on
cerebral blood volume, blood flow, and vascular mean transit time. Stroke 5:630–639,
1974.
140.
Gibbs JM, Wise RJS, Leenders KL, Jones T: Evaluation
of cerebral perfusion reserve in patients with carotid-artery occlusion. Lancet
1:310–314, 1984.
141.
Montgomery EB, Grubb RL, Raichle ME: Cerebral
hemodynamics and metabolism in postoperative cerebral vasospasm and treatment with
hypertensive therapy. Ann Neurol 9:503–506, 1981.
142.
Ferrari M, Wilson DA, Hanley DF, Traystman RJ:
Effects of graded hypotension on cerebral blood flow, blood volume, and mean transit
time in dogs. Am J Physiol 262:H1908–H1914, 1992.
143.
Lanier WL, Warner DO: Intracranial elastance
versus intracranial compliance: Terminology should agree with that of other disciplines
[letter]. Anesthesiology 77:403–404, 1992.
144.
Artru AA: Relationship between cerebral blood
volume and CSF pressure during anesthesia with isoflurane or fentanyl in dogs. Anesthesiology
60:575–579, 1984.
145.
Artru AA: Relationship between cerebral blood
volume and CSF pressure during anesthesia with halothane or enflurane in dogs. Anesthesiology
58:533–539, 1983.
146.
Archer DP, Labreque P, Tyler JL, et al: Cerebral
blood volume is increased in dogs during administration of nitrous oxide or isoflurane.
Anesthesiology 67:642–648, 1987.
147.
Weeks JB, Todd MM, Warner DS, Katz J: The influence
of halothane, isoflurane, and pentobarbital on cerebral plasma volume in hypocapnic
and normocapnic rats. Anesthesiology 73:461–466, 1990.
148.
Ulrich K, Kuschinsky W: In vivo effects of alpha-adrenoceptor
agonists and antagonists on pial veins of cats. Stroke 16:880–884, 1985.
149.
Pierce EC, Lambertsen CJ, Deutsch S, et al: Cerebral
circulation and metabolism during thiopental anesthesia and hyperventilation in man.
J Clin Invest 41:1664–1671, 1962.
150.
Stephan H, Sonntag H, Schenk HD, Kohlhausen S:
Effects of Disoprivan (propofol) on the circulation and oxygen consumption of the
brain and CO2
reactivity of brain vessels in the human [in German]. Anaesthesist
36:60–65, 1987.
